Lv1
20 积分 2025-05-03 加入
Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation
7个月前
已完结
Sarcopenic obesity in older adults: a clinical overview
8个月前
已完结
Metabolically healthy versus metabolically unhealthy obesity
8个月前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial
8个月前
已完结
GLP-1 and amylin receptor multiagonism with amycretin for obesity management
8个月前
已完结
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice
8个月前
已完结
皖公网安备34019202002308
